nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxocobalamin—MTR—type 2 diabetes mellitus	0.565	1	CbGaD
Hydroxocobalamin—Cyanocobalamin—MTR—type 2 diabetes mellitus	0.00419	0.745	CrCbGaD
Hydroxocobalamin—AMN—nephron tubule—type 2 diabetes mellitus	0.00274	0.0376	CbGeAlD
Hydroxocobalamin—TCN1—islet of Langerhans—type 2 diabetes mellitus	0.00258	0.0354	CbGeAlD
Hydroxocobalamin—AMN—kidney—type 2 diabetes mellitus	0.00241	0.0331	CbGeAlD
Hydroxocobalamin—CASP9—islet of Langerhans—type 2 diabetes mellitus	0.00238	0.0326	CbGeAlD
Hydroxocobalamin—AMN—cortex of kidney—type 2 diabetes mellitus	0.00235	0.0322	CbGeAlD
Hydroxocobalamin—CUBN—nephron tubule—type 2 diabetes mellitus	0.00231	0.0317	CbGeAlD
Hydroxocobalamin—CUBN—kidney—type 2 diabetes mellitus	0.00203	0.0278	CbGeAlD
Hydroxocobalamin—CUBN—cortex of kidney—type 2 diabetes mellitus	0.00198	0.0271	CbGeAlD
Hydroxocobalamin—CASP9—nephron tubule—type 2 diabetes mellitus	0.00191	0.0262	CbGeAlD
Hydroxocobalamin—TCN2—nephron tubule—type 2 diabetes mellitus	0.00187	0.0256	CbGeAlD
Hydroxocobalamin—MMACHC—liver—type 2 diabetes mellitus	0.00185	0.0254	CbGeAlD
Hydroxocobalamin—CUBN—adipose tissue—type 2 diabetes mellitus	0.00183	0.0251	CbGeAlD
Hydroxocobalamin—MUT—islet of Langerhans—type 2 diabetes mellitus	0.00182	0.025	CbGeAlD
Hydroxocobalamin—TCN1—pancreas—type 2 diabetes mellitus	0.00182	0.0249	CbGeAlD
Hydroxocobalamin—MMAB—cortex of kidney—type 2 diabetes mellitus	0.00175	0.024	CbGeAlD
Hydroxocobalamin—MMAA—adipose tissue—type 2 diabetes mellitus	0.00173	0.0237	CbGeAlD
Hydroxocobalamin—CASP9—kidney—type 2 diabetes mellitus	0.00168	0.0231	CbGeAlD
Hydroxocobalamin—CASP9—pancreas—type 2 diabetes mellitus	0.00167	0.0229	CbGeAlD
Hydroxocobalamin—TCN2—kidney—type 2 diabetes mellitus	0.00164	0.0225	CbGeAlD
Hydroxocobalamin—CASP9—cortex of kidney—type 2 diabetes mellitus	0.00164	0.0225	CbGeAlD
Hydroxocobalamin—MMAB—adipose tissue—type 2 diabetes mellitus	0.00162	0.0223	CbGeAlD
Hydroxocobalamin—TCN2—cortex of kidney—type 2 diabetes mellitus	0.0016	0.0219	CbGeAlD
Hydroxocobalamin—AMN—liver—type 2 diabetes mellitus	0.00152	0.0209	CbGeAlD
Hydroxocobalamin—CASP9—adipose tissue—type 2 diabetes mellitus	0.00152	0.0208	CbGeAlD
Hydroxocobalamin—TCN2—adipose tissue—type 2 diabetes mellitus	0.00148	0.0203	CbGeAlD
Hydroxocobalamin—MUT—nephron tubule—type 2 diabetes mellitus	0.00147	0.0201	CbGeAlD
Hydroxocobalamin—Cyanocobalamin—MTHFR—type 2 diabetes mellitus	0.00143	0.255	CrCbGaD
Hydroxocobalamin—MTRR—nephron tubule—type 2 diabetes mellitus	0.00132	0.0181	CbGeAlD
Hydroxocobalamin—MUT—cardiovascular system—type 2 diabetes mellitus	0.00132	0.0181	CbGeAlD
Hydroxocobalamin—MUT—kidney—type 2 diabetes mellitus	0.00129	0.0177	CbGeAlD
Hydroxocobalamin—MUT—pancreas—type 2 diabetes mellitus	0.00128	0.0176	CbGeAlD
Hydroxocobalamin—MUT—cortex of kidney—type 2 diabetes mellitus	0.00126	0.0172	CbGeAlD
Hydroxocobalamin—MMAA—liver—type 2 diabetes mellitus	0.00121	0.0166	CbGeAlD
Hydroxocobalamin—MUT—adipose tissue—type 2 diabetes mellitus	0.00116	0.016	CbGeAlD
Hydroxocobalamin—MTRR—kidney—type 2 diabetes mellitus	0.00116	0.0159	CbGeAlD
Hydroxocobalamin—MTR—nephron tubule—type 2 diabetes mellitus	0.00115	0.0158	CbGeAlD
Hydroxocobalamin—MMAB—liver—type 2 diabetes mellitus	0.00114	0.0156	CbGeAlD
Hydroxocobalamin—MTRR—cortex of kidney—type 2 diabetes mellitus	0.00113	0.0155	CbGeAlD
Hydroxocobalamin—CASP9—liver—type 2 diabetes mellitus	0.00106	0.0146	CbGeAlD
Hydroxocobalamin—MTRR—adipose tissue—type 2 diabetes mellitus	0.00105	0.0143	CbGeAlD
Hydroxocobalamin—TCN2—liver—type 2 diabetes mellitus	0.00104	0.0142	CbGeAlD
Hydroxocobalamin—MTR—cardiovascular system—type 2 diabetes mellitus	0.00103	0.0142	CbGeAlD
Hydroxocobalamin—MTR—kidney—type 2 diabetes mellitus	0.00101	0.0139	CbGeAlD
Hydroxocobalamin—MTR—pancreas—type 2 diabetes mellitus	0.00101	0.0138	CbGeAlD
Hydroxocobalamin—MTR—cortex of kidney—type 2 diabetes mellitus	0.000985	0.0135	CbGeAlD
Hydroxocobalamin—MTR—adipose tissue—type 2 diabetes mellitus	0.000912	0.0125	CbGeAlD
Hydroxocobalamin—MUT—liver—type 2 diabetes mellitus	0.000816	0.0112	CbGeAlD
Hydroxocobalamin—MTRR—liver—type 2 diabetes mellitus	0.000733	0.0101	CbGeAlD
Hydroxocobalamin—MTR—liver—type 2 diabetes mellitus	0.000639	0.00877	CbGeAlD
Hydroxocobalamin—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000232	0.00153	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000232	0.00153	CcSEcCtD
Hydroxocobalamin—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000231	0.00152	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Bromocriptine—type 2 diabetes mellitus	0.000231	0.00152	CcSEcCtD
Hydroxocobalamin—Abdominal discomfort—Ramipril—type 2 diabetes mellitus	0.000228	0.0015	CcSEcCtD
Hydroxocobalamin—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000228	0.0015	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000228	0.0015	CcSEcCtD
Hydroxocobalamin—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.000227	0.0015	CcSEcCtD
Hydroxocobalamin—Angiopathy—Metformin—type 2 diabetes mellitus	0.000227	0.0015	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000226	0.00149	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000226	0.00149	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000225	0.00149	CcSEcCtD
Hydroxocobalamin—Chills—Metformin—type 2 diabetes mellitus	0.000224	0.00148	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000223	0.00147	CcSEcCtD
Hydroxocobalamin—Chest pain—Gliclazide—type 2 diabetes mellitus	0.000222	0.00146	CcSEcCtD
Hydroxocobalamin—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000221	0.00146	CcSEcCtD
Hydroxocobalamin—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000221	0.00146	CcSEcCtD
Hydroxocobalamin—Nausea—Repaglinide—type 2 diabetes mellitus	0.000221	0.00145	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.00022	0.00145	CcSEcCtD
Hydroxocobalamin—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00022	0.00145	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.000219	0.00144	CcSEcCtD
Hydroxocobalamin—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000219	0.00144	CcSEcCtD
Hydroxocobalamin—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000219	0.00144	CcSEcCtD
Hydroxocobalamin—Angioedema—Valsartan—type 2 diabetes mellitus	0.000218	0.00144	CcSEcCtD
Hydroxocobalamin—Erythema—Metformin—type 2 diabetes mellitus	0.000218	0.00143	CcSEcCtD
Hydroxocobalamin—Pruritus—Glipizide—type 2 diabetes mellitus	0.000217	0.00143	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000217	0.00143	CcSEcCtD
Hydroxocobalamin—Angioedema—Orlistat—type 2 diabetes mellitus	0.000216	0.00142	CcSEcCtD
Hydroxocobalamin—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.000214	0.00141	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000213	0.00141	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000213	0.0014	CcSEcCtD
Hydroxocobalamin—Malaise—Orlistat—type 2 diabetes mellitus	0.000213	0.0014	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000213	0.0014	CcSEcCtD
Hydroxocobalamin—Chills—Irbesartan—type 2 diabetes mellitus	0.000212	0.0014	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000211	0.00139	CcSEcCtD
Hydroxocobalamin—Infection—Gliclazide—type 2 diabetes mellitus	0.000211	0.00139	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000211	0.00139	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Irbesartan—type 2 diabetes mellitus	0.000211	0.00139	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000211	0.00139	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.00021	0.00139	CcSEcCtD
Hydroxocobalamin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000209	0.00137	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000208	0.00137	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000208	0.00137	CcSEcCtD
Hydroxocobalamin—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.000207	0.00137	CcSEcCtD
Hydroxocobalamin—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000206	0.00136	CcSEcCtD
Hydroxocobalamin—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000206	0.00135	CcSEcCtD
Hydroxocobalamin—Erythema—Irbesartan—type 2 diabetes mellitus	0.000205	0.00135	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000205	0.00135	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000204	0.00135	CcSEcCtD
Hydroxocobalamin—Chest pain—Valsartan—type 2 diabetes mellitus	0.000204	0.00134	CcSEcCtD
Hydroxocobalamin—Dizziness—Glipizide—type 2 diabetes mellitus	0.000203	0.00134	CcSEcCtD
Hydroxocobalamin—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000203	0.00134	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000202	0.00133	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000202	0.00133	CcSEcCtD
Hydroxocobalamin—Angiopathy—Losartan—type 2 diabetes mellitus	0.000202	0.00133	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000201	0.00133	CcSEcCtD
Hydroxocobalamin—Chest pain—Orlistat—type 2 diabetes mellitus	0.000201	0.00133	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.0002	0.00132	CcSEcCtD
Hydroxocobalamin—Discomfort—Orlistat—type 2 diabetes mellitus	0.000199	0.00131	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000198	0.00131	CcSEcCtD
Hydroxocobalamin—Malaise—Metformin—type 2 diabetes mellitus	0.000196	0.00129	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000196	0.00129	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000196	0.00129	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000195	0.00129	CcSEcCtD
Hydroxocobalamin—Oedema—Valsartan—type 2 diabetes mellitus	0.000195	0.00129	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000195	0.00128	CcSEcCtD
Hydroxocobalamin—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000195	0.00128	CcSEcCtD
Hydroxocobalamin—Infection—Valsartan—type 2 diabetes mellitus	0.000194	0.00128	CcSEcCtD
Hydroxocobalamin—Rash—Glipizide—type 2 diabetes mellitus	0.000194	0.00128	CcSEcCtD
Hydroxocobalamin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000194	0.00128	CcSEcCtD
Hydroxocobalamin—Erythema—Losartan—type 2 diabetes mellitus	0.000193	0.00127	CcSEcCtD
Hydroxocobalamin—Oedema—Orlistat—type 2 diabetes mellitus	0.000193	0.00127	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000193	0.00127	CcSEcCtD
Hydroxocobalamin—Headache—Glipizide—type 2 diabetes mellitus	0.000193	0.00127	CcSEcCtD
Hydroxocobalamin—Infection—Orlistat—type 2 diabetes mellitus	0.000192	0.00126	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000191	0.00126	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000191	0.00126	CcSEcCtD
Hydroxocobalamin—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00019	0.00125	CcSEcCtD
Hydroxocobalamin—Skin disorder—Valsartan—type 2 diabetes mellitus	0.00019	0.00125	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000189	0.00125	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000189	0.00125	CcSEcCtD
Hydroxocobalamin—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000189	0.00125	CcSEcCtD
Hydroxocobalamin—Agitation—Irbesartan—type 2 diabetes mellitus	0.000189	0.00124	CcSEcCtD
Hydroxocobalamin—Urticaria—Glyburide—type 2 diabetes mellitus	0.000188	0.00124	CcSEcCtD
Hydroxocobalamin—Angioedema—Irbesartan—type 2 diabetes mellitus	0.000188	0.00124	CcSEcCtD
Hydroxocobalamin—Oedema peripheral—Ramipril—type 2 diabetes mellitus	0.000188	0.00124	CcSEcCtD
Hydroxocobalamin—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000187	0.00123	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000187	0.00123	CcSEcCtD
Hydroxocobalamin—Chest pain—Metformin—type 2 diabetes mellitus	0.000185	0.00122	CcSEcCtD
Hydroxocobalamin—Malaise—Irbesartan—type 2 diabetes mellitus	0.000185	0.00122	CcSEcCtD
Hydroxocobalamin—Headache—Pioglitazone—type 2 diabetes mellitus	0.000184	0.00122	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000184	0.00121	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000183	0.00121	CcSEcCtD
Hydroxocobalamin—Discomfort—Metformin—type 2 diabetes mellitus	0.000183	0.00121	CcSEcCtD
Hydroxocobalamin—Nausea—Glipizide—type 2 diabetes mellitus	0.000183	0.0012	CcSEcCtD
Hydroxocobalamin—Pain—Gliclazide—type 2 diabetes mellitus	0.000182	0.0012	CcSEcCtD
Hydroxocobalamin—Rash—Glimepiride—type 2 diabetes mellitus	0.000181	0.00119	CcSEcCtD
Hydroxocobalamin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000181	0.00119	CcSEcCtD
Hydroxocobalamin—Rash—Sitagliptin—type 2 diabetes mellitus	0.00018	0.00119	CcSEcCtD
Hydroxocobalamin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00018	0.00119	CcSEcCtD
Hydroxocobalamin—Headache—Glimepiride—type 2 diabetes mellitus	0.00018	0.00118	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000179	0.00118	CcSEcCtD
Hydroxocobalamin—Headache—Sitagliptin—type 2 diabetes mellitus	0.000179	0.00118	CcSEcCtD
Hydroxocobalamin—Agitation—Losartan—type 2 diabetes mellitus	0.000178	0.00117	CcSEcCtD
Hydroxocobalamin—Oedema—Metformin—type 2 diabetes mellitus	0.000178	0.00117	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000177	0.00117	CcSEcCtD
Hydroxocobalamin—Angioedema—Losartan—type 2 diabetes mellitus	0.000177	0.00116	CcSEcCtD
Hydroxocobalamin—Infection—Metformin—type 2 diabetes mellitus	0.000177	0.00116	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000175	0.00115	CcSEcCtD
Hydroxocobalamin—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000175	0.00115	CcSEcCtD
Hydroxocobalamin—Malaise—Losartan—type 2 diabetes mellitus	0.000174	0.00115	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000174	0.00115	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000174	0.00115	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000174	0.00115	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000174	0.00114	CcSEcCtD
Hydroxocobalamin—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000173	0.00114	CcSEcCtD
Hydroxocobalamin—Skin disorder—Metformin—type 2 diabetes mellitus	0.000173	0.00114	CcSEcCtD
Hydroxocobalamin—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000172	0.00113	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.000172	0.00113	CcSEcCtD
Hydroxocobalamin—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000172	0.00113	CcSEcCtD
Hydroxocobalamin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000171	0.00113	CcSEcCtD
Hydroxocobalamin—Nausea—Glimepiride—type 2 diabetes mellitus	0.00017	0.00112	CcSEcCtD
Hydroxocobalamin—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.00017	0.00112	CcSEcCtD
Hydroxocobalamin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00017	0.00112	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.00017	0.00112	CcSEcCtD
Hydroxocobalamin—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000169	0.00111	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000168	0.00111	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000168	0.00111	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000168	0.00111	CcSEcCtD
Hydroxocobalamin—Oedema—Irbesartan—type 2 diabetes mellitus	0.000168	0.00111	CcSEcCtD
Hydroxocobalamin—Pruritus—Glyburide—type 2 diabetes mellitus	0.000167	0.0011	CcSEcCtD
Hydroxocobalamin—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000167	0.0011	CcSEcCtD
Hydroxocobalamin—Infection—Irbesartan—type 2 diabetes mellitus	0.000167	0.0011	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000166	0.0011	CcSEcCtD
Hydroxocobalamin—Erythema—Ramipril—type 2 diabetes mellitus	0.000166	0.00109	CcSEcCtD
Hydroxocobalamin—Pain—Orlistat—type 2 diabetes mellitus	0.000165	0.00109	CcSEcCtD
Hydroxocobalamin—Chest pain—Losartan—type 2 diabetes mellitus	0.000165	0.00108	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000164	0.00108	CcSEcCtD
Hydroxocobalamin—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000164	0.00108	CcSEcCtD
Hydroxocobalamin—Rash—Bromocriptine—type 2 diabetes mellitus	0.000163	0.00108	CcSEcCtD
Hydroxocobalamin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000163	0.00107	CcSEcCtD
Hydroxocobalamin—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000163	0.00107	CcSEcCtD
Hydroxocobalamin—Discomfort—Losartan—type 2 diabetes mellitus	0.000163	0.00107	CcSEcCtD
Hydroxocobalamin—Headache—Bromocriptine—type 2 diabetes mellitus	0.000162	0.00107	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000162	0.00107	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000159	0.00105	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000158	0.00104	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000158	0.00104	CcSEcCtD
Hydroxocobalamin—Oedema—Losartan—type 2 diabetes mellitus	0.000158	0.00104	CcSEcCtD
Hydroxocobalamin—Infection—Losartan—type 2 diabetes mellitus	0.000157	0.00103	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000156	0.00103	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000156	0.00103	CcSEcCtD
Hydroxocobalamin—Urticaria—Valsartan—type 2 diabetes mellitus	0.000155	0.00102	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000155	0.00102	CcSEcCtD
Hydroxocobalamin—Tachycardia—Losartan—type 2 diabetes mellitus	0.000154	0.00101	CcSEcCtD
Hydroxocobalamin—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000154	0.00101	CcSEcCtD
Hydroxocobalamin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000154	0.00101	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000153	0.00101	CcSEcCtD
Hydroxocobalamin—Urticaria—Orlistat—type 2 diabetes mellitus	0.000153	0.00101	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000152	0.001	CcSEcCtD
Hydroxocobalamin—Agitation—Ramipril—type 2 diabetes mellitus	0.000152	0.001	CcSEcCtD
Hydroxocobalamin—Angioedema—Ramipril—type 2 diabetes mellitus	0.000151	0.000998	CcSEcCtD
Hydroxocobalamin—Pruritus—Gliclazide—type 2 diabetes mellitus	0.00015	0.00099	CcSEcCtD
Hydroxocobalamin—Malaise—Ramipril—type 2 diabetes mellitus	0.00015	0.000985	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000149	0.000985	CcSEcCtD
Hydroxocobalamin—Rash—Glyburide—type 2 diabetes mellitus	0.000149	0.000983	CcSEcCtD
Hydroxocobalamin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000149	0.000982	CcSEcCtD
Hydroxocobalamin—Headache—Glyburide—type 2 diabetes mellitus	0.000148	0.000976	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000148	0.000973	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000146	0.000965	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000145	0.000958	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000145	0.000954	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000144	0.000947	CcSEcCtD
Hydroxocobalamin—Pain—Irbesartan—type 2 diabetes mellitus	0.000143	0.000945	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000142	0.000936	CcSEcCtD
Hydroxocobalamin—Urticaria—Metformin—type 2 diabetes mellitus	0.000141	0.00093	CcSEcCtD
Hydroxocobalamin—Chest pain—Ramipril—type 2 diabetes mellitus	0.000141	0.00093	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000141	0.000927	CcSEcCtD
Hydroxocobalamin—Nausea—Glyburide—type 2 diabetes mellitus	0.00014	0.000926	CcSEcCtD
Hydroxocobalamin—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00014	0.000926	CcSEcCtD
Hydroxocobalamin—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.00014	0.000924	CcSEcCtD
Hydroxocobalamin—Discomfort—Ramipril—type 2 diabetes mellitus	0.000139	0.000919	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000139	0.000915	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000138	0.000911	CcSEcCtD
Hydroxocobalamin—Pruritus—Valsartan—type 2 diabetes mellitus	0.000138	0.00091	CcSEcCtD
Hydroxocobalamin—Pruritus—Orlistat—type 2 diabetes mellitus	0.000136	0.000899	CcSEcCtD
Hydroxocobalamin—Oedema—Ramipril—type 2 diabetes mellitus	0.000135	0.000892	CcSEcCtD
Hydroxocobalamin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000135	0.000892	CcSEcCtD
Hydroxocobalamin—Pain—Losartan—type 2 diabetes mellitus	0.000135	0.000889	CcSEcCtD
Hydroxocobalamin—Rash—Gliclazide—type 2 diabetes mellitus	0.000134	0.000882	CcSEcCtD
Hydroxocobalamin—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000134	0.000882	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000134	0.00088	CcSEcCtD
Hydroxocobalamin—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000133	0.000878	CcSEcCtD
Hydroxocobalamin—Headache—Gliclazide—type 2 diabetes mellitus	0.000133	0.000877	CcSEcCtD
Hydroxocobalamin—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000133	0.000874	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000133	0.000874	CcSEcCtD
Hydroxocobalamin—Tachycardia—Ramipril—type 2 diabetes mellitus	0.000132	0.00087	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.000132	0.000869	CcSEcCtD
Hydroxocobalamin—Skin disorder—Ramipril—type 2 diabetes mellitus	0.000131	0.000866	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00013	0.000857	CcSEcCtD
Hydroxocobalamin—Dizziness—Valsartan—type 2 diabetes mellitus	0.000129	0.00085	CcSEcCtD
Hydroxocobalamin—Dizziness—Orlistat—type 2 diabetes mellitus	0.000127	0.00084	CcSEcCtD
Hydroxocobalamin—Nausea—Gliclazide—type 2 diabetes mellitus	0.000126	0.000831	CcSEcCtD
Hydroxocobalamin—Pruritus—Metformin—type 2 diabetes mellitus	0.000126	0.000828	CcSEcCtD
Hydroxocobalamin—Urticaria—Losartan—type 2 diabetes mellitus	0.000125	0.000826	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000125	0.000822	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000124	0.000814	CcSEcCtD
Hydroxocobalamin—Rash—Valsartan—type 2 diabetes mellitus	0.000123	0.000811	CcSEcCtD
Hydroxocobalamin—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000123	0.00081	CcSEcCtD
Hydroxocobalamin—Headache—Valsartan—type 2 diabetes mellitus	0.000122	0.000806	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000122	0.000801	CcSEcCtD
Hydroxocobalamin—Rash—Orlistat—type 2 diabetes mellitus	0.000122	0.000801	CcSEcCtD
Hydroxocobalamin—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000121	0.0008	CcSEcCtD
Hydroxocobalamin—Headache—Orlistat—type 2 diabetes mellitus	0.000121	0.000796	CcSEcCtD
Hydroxocobalamin—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000121	0.000795	CcSEcCtD
Hydroxocobalamin—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000119	0.000785	CcSEcCtD
Hydroxocobalamin—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000119	0.000782	CcSEcCtD
Hydroxocobalamin—Dizziness—Metformin—type 2 diabetes mellitus	0.000117	0.000774	CcSEcCtD
Hydroxocobalamin—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000117	0.00077	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000116	0.000766	CcSEcCtD
Hydroxocobalamin—Nausea—Valsartan—type 2 diabetes mellitus	0.000116	0.000764	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000115	0.000756	CcSEcCtD
Hydroxocobalamin—Nausea—Orlistat—type 2 diabetes mellitus	0.000115	0.000755	CcSEcCtD
Hydroxocobalamin—Rash—Metformin—type 2 diabetes mellitus	0.000112	0.000738	CcSEcCtD
Hydroxocobalamin—Dermatitis—Metformin—type 2 diabetes mellitus	0.000112	0.000738	CcSEcCtD
Hydroxocobalamin—Pruritus—Losartan—type 2 diabetes mellitus	0.000112	0.000736	CcSEcCtD
Hydroxocobalamin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000112	0.000735	CcSEcCtD
Hydroxocobalamin—Headache—Metformin—type 2 diabetes mellitus	0.000111	0.000734	CcSEcCtD
Hydroxocobalamin—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000111	0.000731	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000108	0.000712	CcSEcCtD
Hydroxocobalamin—Urticaria—Ramipril—type 2 diabetes mellitus	0.000107	0.000708	CcSEcCtD
Hydroxocobalamin—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000107	0.000705	CcSEcCtD
Hydroxocobalamin—Rash—Irbesartan—type 2 diabetes mellitus	0.000106	0.000697	CcSEcCtD
Hydroxocobalamin—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000106	0.000696	CcSEcCtD
Hydroxocobalamin—Nausea—Metformin—type 2 diabetes mellitus	0.000106	0.000696	CcSEcCtD
Hydroxocobalamin—Headache—Irbesartan—type 2 diabetes mellitus	0.000105	0.000692	CcSEcCtD
Hydroxocobalamin—Dizziness—Losartan—type 2 diabetes mellitus	0.000104	0.000688	CcSEcCtD
Hydroxocobalamin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	9.97e-05	0.000657	CcSEcCtD
Hydroxocobalamin—Nausea—Irbesartan—type 2 diabetes mellitus	9.96e-05	0.000656	CcSEcCtD
Hydroxocobalamin—Rash—Losartan—type 2 diabetes mellitus	9.95e-05	0.000656	CcSEcCtD
Hydroxocobalamin—Dermatitis—Losartan—type 2 diabetes mellitus	9.94e-05	0.000655	CcSEcCtD
Hydroxocobalamin—Headache—Losartan—type 2 diabetes mellitus	9.89e-05	0.000652	CcSEcCtD
Hydroxocobalamin—Pruritus—Ramipril—type 2 diabetes mellitus	9.57e-05	0.000631	CcSEcCtD
Hydroxocobalamin—Nausea—Losartan—type 2 diabetes mellitus	9.37e-05	0.000618	CcSEcCtD
Hydroxocobalamin—Diarrhoea—Ramipril—type 2 diabetes mellitus	9.26e-05	0.00061	CcSEcCtD
Hydroxocobalamin—Dizziness—Ramipril—type 2 diabetes mellitus	8.95e-05	0.00059	CcSEcCtD
Hydroxocobalamin—Rash—Ramipril—type 2 diabetes mellitus	8.53e-05	0.000562	CcSEcCtD
Hydroxocobalamin—Dermatitis—Ramipril—type 2 diabetes mellitus	8.52e-05	0.000562	CcSEcCtD
Hydroxocobalamin—Headache—Ramipril—type 2 diabetes mellitus	8.48e-05	0.000559	CcSEcCtD
Hydroxocobalamin—Nausea—Ramipril—type 2 diabetes mellitus	8.04e-05	0.00053	CcSEcCtD
Hydroxocobalamin—MTRR—Disease—IRS1—type 2 diabetes mellitus	9.58e-06	4.68e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—PTGS2—type 2 diabetes mellitus	9.56e-06	4.67e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—HMOX1—type 2 diabetes mellitus	9.56e-06	4.67e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PPARG—type 2 diabetes mellitus	9.54e-06	4.66e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—EGFR—type 2 diabetes mellitus	9.52e-06	4.65e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PPARA—type 2 diabetes mellitus	9.48e-06	4.63e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CAT—type 2 diabetes mellitus	9.44e-06	4.61e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—MTHFR—type 2 diabetes mellitus	9.4e-06	4.6e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—INS—type 2 diabetes mellitus	9.36e-06	4.57e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—NOS3—type 2 diabetes mellitus	9.32e-06	4.56e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PIK3R1—type 2 diabetes mellitus	9.32e-06	4.56e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PIK3R1—type 2 diabetes mellitus	9.32e-06	4.56e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—NOS3—type 2 diabetes mellitus	9.32e-06	4.56e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—ALB—type 2 diabetes mellitus	9.3e-06	4.54e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—SRC—type 2 diabetes mellitus	9.24e-06	4.51e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—PIK3R1—type 2 diabetes mellitus	9.18e-06	4.49e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AGT—type 2 diabetes mellitus	9.18e-06	4.49e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—INS—type 2 diabetes mellitus	9.18e-06	4.48e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—APOB—type 2 diabetes mellitus	9.16e-06	4.48e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—CALM1—type 2 diabetes mellitus	9.03e-06	4.41e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	9.02e-06	4.41e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—APOE—type 2 diabetes mellitus	8.99e-06	4.4e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—HIF1A—type 2 diabetes mellitus	8.97e-06	4.38e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IAPP—type 2 diabetes mellitus	8.97e-06	4.38e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—PTGS2—type 2 diabetes mellitus	8.96e-06	4.38e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—IRS2—type 2 diabetes mellitus	8.95e-06	4.37e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—INSR—type 2 diabetes mellitus	8.91e-06	4.36e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GSTM1—type 2 diabetes mellitus	8.91e-06	4.36e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—APOA1—type 2 diabetes mellitus	8.89e-06	4.35e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—NOS3—type 2 diabetes mellitus	8.89e-06	4.35e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PIK3R1—type 2 diabetes mellitus	8.89e-06	4.35e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—TGFB1—type 2 diabetes mellitus	8.88e-06	4.34e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—TGFB1—type 2 diabetes mellitus	8.88e-06	4.34e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—AKT2—type 2 diabetes mellitus	8.87e-06	4.33e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—BCL2—type 2 diabetes mellitus	8.84e-06	4.32e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—PIK3R1—type 2 diabetes mellitus	8.82e-06	4.31e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—CALM1—type 2 diabetes mellitus	8.79e-06	4.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TRPC6—type 2 diabetes mellitus	8.76e-06	4.28e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—APOE—type 2 diabetes mellitus	8.76e-06	4.28e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—LPL—type 2 diabetes mellitus	8.75e-06	4.28e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TGFBR2—type 2 diabetes mellitus	8.72e-06	4.26e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—EGFR—type 2 diabetes mellitus	8.71e-06	4.26e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—EGFR—type 2 diabetes mellitus	8.71e-06	4.26e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AGTR2—type 2 diabetes mellitus	8.71e-06	4.26e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—APOA1—type 2 diabetes mellitus	8.65e-06	4.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—RELA—type 2 diabetes mellitus	8.64e-06	4.22e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—ALB—type 2 diabetes mellitus	8.58e-06	4.19e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ADCY5—type 2 diabetes mellitus	8.56e-06	4.19e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—GPX1—type 2 diabetes mellitus	8.53e-06	4.17e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—PTGS2—type 2 diabetes mellitus	8.52e-06	4.17e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—PTGS2—type 2 diabetes mellitus	8.52e-06	4.17e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CDKN2B—type 2 diabetes mellitus	8.45e-06	4.13e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—SERPINE1—type 2 diabetes mellitus	8.43e-06	4.12e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AGER—type 2 diabetes mellitus	8.37e-06	4.09e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ADCY5—type 2 diabetes mellitus	8.34e-06	4.08e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EDNRB—type 2 diabetes mellitus	8.34e-06	4.07e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CD36—type 2 diabetes mellitus	8.31e-06	4.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—RELA—type 2 diabetes mellitus	8.3e-06	4.06e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—TGFB1—type 2 diabetes mellitus	8.26e-06	4.04e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—APOB—type 2 diabetes mellitus	8.24e-06	4.03e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—SRC—type 2 diabetes mellitus	8.23e-06	4.02e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—SRC—type 2 diabetes mellitus	8.23e-06	4.02e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PPP2CA—type 2 diabetes mellitus	8.21e-06	4.01e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—NOS3—type 2 diabetes mellitus	8.21e-06	4.01e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PIK3R1—type 2 diabetes mellitus	8.21e-06	4.01e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NOS2—type 2 diabetes mellitus	8.16e-06	3.99e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—PTGS2—type 2 diabetes mellitus	8.13e-06	3.97e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—EGFR—type 2 diabetes mellitus	8.1e-06	3.96e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PSMD6—type 2 diabetes mellitus	8.09e-06	3.96e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HTR2C—type 2 diabetes mellitus	8.09e-06	3.96e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CD36—type 2 diabetes mellitus	8.09e-06	3.96e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PIK3R1—type 2 diabetes mellitus	8.05e-06	3.93e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—NOS3—type 2 diabetes mellitus	8.05e-06	3.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—IL6—type 2 diabetes mellitus	8.02e-06	3.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PPP2CA—type 2 diabetes mellitus	7.99e-06	3.91e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—MTHFR—type 2 diabetes mellitus	7.88e-06	3.85e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EDNRA—type 2 diabetes mellitus	7.87e-06	3.85e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—LPL—type 2 diabetes mellitus	7.86e-06	3.84e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—SRC—type 2 diabetes mellitus	7.85e-06	3.84e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CYBA—type 2 diabetes mellitus	7.84e-06	3.83e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PPARG—type 2 diabetes mellitus	7.83e-06	3.83e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—IRS1—type 2 diabetes mellitus	7.81e-06	3.82e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PPARA—type 2 diabetes mellitus	7.73e-06	3.78e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	7.7e-06	3.77e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—ADCY5—type 2 diabetes mellitus	7.7e-06	3.76e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—INS—type 2 diabetes mellitus	7.68e-06	3.76e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PLAT—type 2 diabetes mellitus	7.67e-06	3.75e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GHRL—type 2 diabetes mellitus	7.67e-06	3.75e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—C3—type 2 diabetes mellitus	7.67e-06	3.75e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CALCA—type 2 diabetes mellitus	7.58e-06	3.7e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—PTGS2—type 2 diabetes mellitus	7.5e-06	3.67e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AGT—type 2 diabetes mellitus	7.48e-06	3.66e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—INS—type 2 diabetes mellitus	7.48e-06	3.66e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling by NGF—AKT1—type 2 diabetes mellitus	7.4e-06	3.62e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PPP2CA—type 2 diabetes mellitus	7.38e-06	3.61e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—TGFB1—type 2 diabetes mellitus	7.36e-06	3.6e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—TGFB1—type 2 diabetes mellitus	7.36e-06	3.6e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—PTGS2—type 2 diabetes mellitus	7.36e-06	3.6e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—CALM1—type 2 diabetes mellitus	7.36e-06	3.6e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—BCL2L1—type 2 diabetes mellitus	7.34e-06	3.59e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—APOE—type 2 diabetes mellitus	7.33e-06	3.58e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—IL6—type 2 diabetes mellitus	7.32e-06	3.58e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IRS2—type 2 diabetes mellitus	7.3e-06	3.57e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CRP—type 2 diabetes mellitus	7.3e-06	3.57e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—NFKB1—type 2 diabetes mellitus	7.29e-06	3.56e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—APOA1—type 2 diabetes mellitus	7.25e-06	3.54e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—SRC—type 2 diabetes mellitus	7.25e-06	3.54e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CCR5—type 2 diabetes mellitus	7.25e-06	3.54e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKT2—type 2 diabetes mellitus	7.23e-06	3.53e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—EGFR—type 2 diabetes mellitus	7.22e-06	3.53e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—EGFR—type 2 diabetes mellitus	7.22e-06	3.53e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CALM1—type 2 diabetes mellitus	7.16e-06	3.5e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	7.14e-06	3.49e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—MTHFR—type 2 diabetes mellitus	7.08e-06	3.46e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—ALB—type 2 diabetes mellitus	7.04e-06	3.44e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—TGFB1—type 2 diabetes mellitus	7.02e-06	3.43e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PTPN1—type 2 diabetes mellitus	7.02e-06	3.43e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GCG—type 2 diabetes mellitus	7.02e-06	3.43e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—NFKB1—type 2 diabetes mellitus	7e-06	3.42e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	6.9e-06	3.37e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—EGFR—type 2 diabetes mellitus	6.88e-06	3.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	6.88e-06	3.36e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SERPINE1—type 2 diabetes mellitus	6.87e-06	3.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—SRC—type 2 diabetes mellitus	6.79e-06	3.32e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—HIF1A—type 2 diabetes mellitus	6.75e-06	3.3e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Disease—AKT1—type 2 diabetes mellitus	6.75e-06	3.3e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—NOS3—type 2 diabetes mellitus	6.74e-06	3.29e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PIK3R1—type 2 diabetes mellitus	6.74e-06	3.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IRS2—type 2 diabetes mellitus	6.74e-06	3.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PRKCB—type 2 diabetes mellitus	6.73e-06	3.29e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—ICAM1—type 2 diabetes mellitus	6.71e-06	3.28e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—IL6—type 2 diabetes mellitus	6.69e-06	3.27e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—IL6—type 2 diabetes mellitus	6.69e-06	3.27e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—CALM1—type 2 diabetes mellitus	6.61e-06	3.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—APOE—type 2 diabetes mellitus	6.59e-06	3.22e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PIK3R1—type 2 diabetes mellitus	6.56e-06	3.21e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—NOS3—type 2 diabetes mellitus	6.56e-06	3.21e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—SRC—type 2 diabetes mellitus	6.52e-06	3.19e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—APOA1—type 2 diabetes mellitus	6.52e-06	3.18e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—TGFB1—type 2 diabetes mellitus	6.48e-06	3.17e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PPARG—type 2 diabetes mellitus	6.39e-06	3.12e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IRS1—type 2 diabetes mellitus	6.37e-06	3.11e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—EGFR—type 2 diabetes mellitus	6.35e-06	3.1e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—INS—type 2 diabetes mellitus	6.26e-06	3.06e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—IL6—type 2 diabetes mellitus	6.22e-06	3.04e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Disease—AKT1—type 2 diabetes mellitus	6.17e-06	3.02e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Disease—AKT1—type 2 diabetes mellitus	6.17e-06	3.02e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—PTGS2—type 2 diabetes mellitus	6.16e-06	3.01e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOS2—type 2 diabetes mellitus	6.14e-06	3e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.1e-06	2.98e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.05e-06	2.96e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—CASP8—type 2 diabetes mellitus	6e-06	2.93e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—PTGS2—type 2 diabetes mellitus	6e-06	2.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP3—type 2 diabetes mellitus	5.97e-06	2.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AVP—type 2 diabetes mellitus	5.97e-06	2.92e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—EGFR—type 2 diabetes mellitus	5.95e-06	2.91e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—SRC—type 2 diabetes mellitus	5.95e-06	2.91e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF2—type 2 diabetes mellitus	5.94e-06	2.9e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.91e-06	2.89e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT2—type 2 diabetes mellitus	5.9e-06	2.88e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IRS1—type 2 diabetes mellitus	5.88e-06	2.87e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—APOB—type 2 diabetes mellitus	5.77e-06	2.82e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.74e-06	2.81e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—ALB—type 2 diabetes mellitus	5.74e-06	2.81e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Disease—AKT1—type 2 diabetes mellitus	5.74e-06	2.81e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—EGFR—type 2 diabetes mellitus	5.72e-06	2.79e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.68e-06	2.77e-05	CbGpPWpGaD
Hydroxocobalamin—MMACHC—Metabolism—AKT1—type 2 diabetes mellitus	5.65e-06	2.76e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—INS—type 2 diabetes mellitus	5.63e-06	2.75e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—IL6—type 2 diabetes mellitus	5.55e-06	2.71e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—IL6—type 2 diabetes mellitus	5.55e-06	2.71e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—LPL—type 2 diabetes mellitus	5.51e-06	2.69e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PIK3R1—type 2 diabetes mellitus	5.49e-06	2.68e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—NOS3—type 2 diabetes mellitus	5.49e-06	2.68e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT2—type 2 diabetes mellitus	5.44e-06	2.66e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.39e-06	2.63e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—PIK3R1—type 2 diabetes mellitus	5.35e-06	2.61e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—TGFB1—type 2 diabetes mellitus	5.32e-06	2.6e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—IL6—type 2 diabetes mellitus	5.29e-06	2.59e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—EGFR—type 2 diabetes mellitus	5.22e-06	2.55e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SERPINE1—type 2 diabetes mellitus	5.17e-06	2.53e-05	CbGpPWpGaD
Hydroxocobalamin—TCN1—Metabolism—AKT1—type 2 diabetes mellitus	5.17e-06	2.53e-05	CbGpPWpGaD
Hydroxocobalamin—MMAB—Metabolism—AKT1—type 2 diabetes mellitus	5.17e-06	2.53e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.17e-06	2.53e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—BCL2—type 2 diabetes mellitus	5.15e-06	2.52e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Disease—AKT1—type 2 diabetes mellitus	5.12e-06	2.5e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Disease—AKT1—type 2 diabetes mellitus	5.12e-06	2.5e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.07e-06	2.48e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—RELA—type 2 diabetes mellitus	5.03e-06	2.46e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—PTGS2—type 2 diabetes mellitus	5.02e-06	2.46e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—C3—type 2 diabetes mellitus	4.96e-06	2.42e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—NOS3—type 2 diabetes mellitus	4.94e-06	2.41e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PIK3R1—type 2 diabetes mellitus	4.94e-06	2.41e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—IL6—type 2 diabetes mellitus	4.88e-06	2.39e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Disease—AKT1—type 2 diabetes mellitus	4.88e-06	2.39e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—SRC—type 2 diabetes mellitus	4.85e-06	2.37e-05	CbGpPWpGaD
Hydroxocobalamin—TCN2—Metabolism—AKT1—type 2 diabetes mellitus	4.81e-06	2.35e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.73e-06	2.31e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.72e-06	2.31e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AGT—type 2 diabetes mellitus	4.71e-06	2.3e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.63e-06	2.26e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—APOE—type 2 diabetes mellitus	4.62e-06	2.26e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—LEP—type 2 diabetes mellitus	4.62e-06	2.26e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—IL6—type 2 diabetes mellitus	4.58e-06	2.24e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.56e-06	2.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—PTGS2—type 2 diabetes mellitus	4.52e-06	2.21e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Disease—AKT1—type 2 diabetes mellitus	4.5e-06	2.2e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.35e-06	2.13e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—TGFB1—type 2 diabetes mellitus	4.34e-06	2.12e-05	CbGpPWpGaD
Hydroxocobalamin—MMAA—Metabolism—AKT1—type 2 diabetes mellitus	4.28e-06	2.09e-05	CbGpPWpGaD
Hydroxocobalamin—AMN—Metabolism—AKT1—type 2 diabetes mellitus	4.28e-06	2.09e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—EGFR—type 2 diabetes mellitus	4.25e-06	2.08e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—NFKB1—type 2 diabetes mellitus	4.25e-06	2.08e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Innate Immune System—AKT1—type 2 diabetes mellitus	4.22e-06	2.06e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.12e-06	2.01e-05	CbGpPWpGaD
Hydroxocobalamin—MUT—Metabolism—AKT1—type 2 diabetes mellitus	4.09e-06	2e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Adaptive Immune System—AKT1—type 2 diabetes mellitus	4.05e-06	1.98e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—IL6—type 2 diabetes mellitus	4.01e-06	1.96e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—SRC—type 2 diabetes mellitus	3.96e-06	1.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—INS—type 2 diabetes mellitus	3.94e-06	1.93e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.88e-06	1.9e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.81e-06	1.86e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.81e-06	1.86e-05	CbGpPWpGaD
Hydroxocobalamin—CUBN—Metabolism—AKT1—type 2 diabetes mellitus	3.77e-06	1.84e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Disease—AKT1—type 2 diabetes mellitus	3.7e-06	1.81e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—SRC—type 2 diabetes mellitus	3.65e-06	1.79e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.62e-06	1.77e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—EGFR—type 2 diabetes mellitus	3.47e-06	1.69e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.46e-06	1.69e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.46e-06	1.69e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—IL6—type 2 diabetes mellitus	3.27e-06	1.6e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—TGFB1—type 2 diabetes mellitus	3.27e-06	1.6e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—RELA—type 2 diabetes mellitus	3.25e-06	1.59e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—EGFR—type 2 diabetes mellitus	3.2e-06	1.56e-05	CbGpPWpGaD
Hydroxocobalamin—MTRR—Metabolism—AKT1—type 2 diabetes mellitus	3.1e-06	1.51e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Disease—AKT1—type 2 diabetes mellitus	3.02e-06	1.47e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.94e-06	1.43e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.77e-06	1.36e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.74e-06	1.34e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—IL6—type 2 diabetes mellitus	2.67e-06	1.3e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—SRC—type 2 diabetes mellitus	2.56e-06	1.25e-05	CbGpPWpGaD
Hydroxocobalamin—MTR—Metabolism—AKT1—type 2 diabetes mellitus	2.53e-06	1.23e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.49e-06	1.22e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—IL6—type 2 diabetes mellitus	2.46e-06	1.2e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Immune System—AKT1—type 2 diabetes mellitus	2.46e-06	1.2e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.29e-06	1.12e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Disease—AKT1—type 2 diabetes mellitus	2.27e-06	1.11e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.24e-06	1.1e-05	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—IL6—type 2 diabetes mellitus	1.72e-06	8.42e-06	CbGpPWpGaD
Hydroxocobalamin—CASP9—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.59e-06	7.77e-06	CbGpPWpGaD
